Posts

Is there an association between HPV vaccination and ant...

Anti-N-methyl-d-aspartate (Anti-NMDA) receptor encephalitis is an acute autoimmu...

Blood-based multi-omics guided detection of a precancer...

A new case report published in the peer-reviewed OMICS: A Journal of Integrative...

Bella moths use poison to attract mates. Scientists are...

Pyrrolizidine alkaloids are as bitter and toxic as they are hard to pronounce. T...

AI tool creates ‘synthetic’ images of cells for enhance...

Observing individual cells through microscopes can reveal a range of important c...

Book aims to re-design the up-skilling game. Rotman Sch...

April 22, 2024 Credit: Mihnea Moldoveanu April 22, 2024 Book Aims to Re-Design t...

SharpeRatio@k: novel metric for evaluation of risk-retu...

Reinforcement learning (RL) is a machine learning technique that trains software...

$1.8M NIH grant will help researchers follow a virus on...

Researchers at the University of Arizona College of Medicine – Tucson were award...

Odor-causing bacteria in armpits targeted using bacteri...

Body odor from the armpits comes from bacteria metabolizing sweat produced by th...

Extracting high-purity gold from electrical and electro...

Korea relies on imports for most of its metal resources, and in recent years, du...

Giant galactic explosion exposes galaxy pollution in ac...

A team of international researchers studied galaxy NGC 4383, in the nearby Virgo...

The FDA cautions against adverse reactions linked to co...

The CDC and the FDA US began a joint investigation to stop the distribution of c...

Cerevel Reports Phase 3 Parkinson’s Success

Within the context of AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics ...

Neumora Schizophrenia Therapy on Hold After Rabbits Fac...

The FDA has halted a phase 1 trial of Neumora Therapeutics’ treatment for schizo...

DF-4101 by AbbVie for Renal Cell Carcinoma: Likelihood ...

DF-4101 is under clinical development by AbbVie and currently in Phase I for Ren...

DF-4101 by AbbVie for Head And Neck Squamous Cell Carci...

DF-4101 is under clinical development by AbbVie and currently in Phase I for Hea...

DF-4101 by AbbVie for Non-Small Cell Lung Cancer: Likel...

DF-4101 is under clinical development by AbbVie and currently in Phase I for Non...